Science Pool

Novel fungal CYP51 inhibitor in Models of Invasive Aspergillosis

Posted by Evotec on Mar 4, 2021 10:44:55 PM

Tags: Articles & Whitepapers, Anti-Infectives

Simultaneous Quantitation of Enmetazobactam and Cefepime in Human Plasma

Posted by Evotec on Mar 4, 2021 10:42:22 PM

Tags: Articles & Whitepapers, Anti-Infectives

Time-kill Kinetics of Antibacterials against Different Ribotypes of Clostridium Difficile

Posted by Evotec on Mar 4, 2021 10:36:40 PM

Tags: Articles & Whitepapers, Anti-Infectives

Potentiation of Antibiotic Activity by a Novel Cationic Peptide

Posted by Evotec on Mar 4, 2021 10:02:48 PM

Tags: Articles & Whitepapers, Anti-Infectives

Drug Discovery Insights: Evotec's Approach to Fighting Chikungunya

Posted by Evotec on Mar 4, 2021 9:20:41 PM

Tags: Articles & Whitepapers, Anti-Infectives

In Vitro Susceptibility of Clostridium Difficile to SMT19969

Posted by Evotec on Mar 2, 2021 1:01:55 PM

Tags: Articles & Whitepapers, Anti-Infectives

Potentiation of Antibiotic Activity by a Novel Cationic Peptide, SPR741

Posted by Evotec on Feb 24, 2021 1:17:53 PM

Tags: Posters, Anti-Infectives

The Use of QED to Estimate Antibacterial Drug-Likeness

Posted by Evotec on Feb 24, 2021 1:14:54 PM

Tags: Medicinal Chemistry, Posters, Anti-Infectives

Efficacy of BAL30072 on Resistant Gram Negative Bacteria

Posted by Evotec on Feb 24, 2021 1:13:39 PM

Tags: Posters, In vivo Pharmacology, Anti-Infectives

In Vitro and In Vivo Characterization of FG-630 LpxC Inhibitor

Posted by Evotec on Feb 24, 2021 12:47:15 PM

Tags: Posters, In vivo Pharmacology, Anti-Infectives